Cargando…
Evolving management of metaplasia and dysplasia in Barrett's epithelium
Oesophageal cancer affects more than 450000 people worldwide and despite continued medical advancements the incidence of oesophageal cancer is increasing. Oesophageal cancer has a 5 year survival of 15%-25% and now globally attempts are made to more aggressively diagnose and treat Barrett’s oesophag...
Autores principales: | Evans, Richard P T, Mourad, Moustafa Mabrouk, Fisher, Simon G, Bramhall, Simon R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175244/ https://www.ncbi.nlm.nih.gov/pubmed/28058012 http://dx.doi.org/10.3748/wjg.v22.i47.10316 |
Ejemplares similares
-
Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation
por: Raphael, Kara L, et al.
Publicado: (2020) -
Evolving screening and surveillance techniques for Barrett's esophagus
por: Steele, David, et al.
Publicado: (2019) -
Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence
por: Bannister, J. R., et al.
Publicado: (2012) -
Pancreatitis: Preventing catastrophic haemorrhage
por: Evans, Richard PT, et al.
Publicado: (2017) -
Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence
por: Griffiths, E A, et al.
Publicado: (2007)